Genetic determinants of aromatase inhibitor-related arthralgia: the B-ABLE cohort study
- 19 July 2013
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 140 (2) , 385-395
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Predictors of Aromatase Inhibitor Discontinuation as a Result of Treatment-Emergent Symptoms in Early-Stage Breast CancerJournal of Clinical Oncology, 2012
- Association of functional polymorphisms in CYP19A1 with aromatase inhibitor associated arthralgia in breast cancer survivorsBreast Cancer Research, 2011
- Genome-Wide Associations and Functional Genomic Studies of Musculoskeletal Adverse Events in Women Receiving Aromatase InhibitorsJournal of Clinical Oncology, 2010
- Vitamin D deficiency and bone mineral density in postmenopausal women receiving aromatase inhibitors for early breast cancerMaturitas, 2010
- Prospective Study to Assess Short-Term Intra-Articular and Tenosynovial Changes in the Aromatase Inhibitor–Associated Arthralgia SyndromeJournal of Clinical Oncology, 2008
- Selective Estrogen Receptor-β Agonists Repress Transcription of Proinflammatory GenesThe Journal of Immunology, 2008
- Prevalence of Joint Symptoms in Postmenopausal Women Taking Aromatase Inhibitors for Early-Stage Breast CancerJournal of Clinical Oncology, 2007
- Aromatase inhibitors and the syndrome of arthralgias with estrogen deprivationArthritis & Rheumatism, 2005
- Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early‐stage breast cancerCancer, 2003
- Sex hormones and pain: A new role for brain aromatase?Journal of Comparative Neurology, 2000